A study by Martimer et al. aimed to determine if 18F-FDG and FES can detect hormone-induced changes in tumor metabolism and ER levels before and after tamoxifen treatment, and if these PET findings could predict hormonally responsive breast cancer. The gene discussed is ESR1; the disease is breast cancer.